Nasal Covid19 Vaccine : Trial To Begin Soon By Serum Institute & Bharat Biotech

सरकारी योजना के लिए जुड़े Join Now
खबरें Telegram पर पाने के लिए जुड़े Join Now

New Delhi : Coronavirus continues to wreak havoc in the country. More than 74 lakh people have been infected with Coronavirus in India and more than 1 lakh 12 thousand have lost their lives. Scientists are also working day and night in the country to find Coronavirus Vaccine. It is expected that the Corona vaccine will be available at the end of the year or early next year. Meanwhile, Union Health Minister Harshwardhan said that no intranasal vaccine trial is going on in India yet, although Serum Institute in collaboration with the American biotech company Codagenix Inc for the elimination of SARS-CoV-2 CDX-005 has started vaccine manufacturing.

Health Minister Harsh Vardhan said on Sunday in his weekly program Sunday Samvad that the CDX-005 vaccine will be an intranasal vaccine, which has been tested on animals. Now the company will start trial of the first phase of this vaccine in the UK by the end of this year. Harshvardhan said that Codagenix will start its human trial process in the UK itself. At the same time, Serum Institute of India will be given responsibility for clinical trials in India of this vaccine.

Bharat Biotech also in the race
Health Minister Harsh Vardhan said that Bharat Biotech has tied up with the Washington School of Medicine regarding the intranasal vaccine. Whose trial, production and marketing will be given to Bharat Biotech. The first phase of this trial will be held at St. Louis University Vaccine and Treatment and Evolution Trial Unit. After which Bharat Biotech will take up the clinical trial in the country after getting approval of the Registry based on its receipts.

Back to top button